Pacira BioSciences, Inc. Common Stock PCRX
$23.00
-0.78%
at last close
Financials (TTM)
- Revenue
- $746.16 million
- Net Income
- $14.64 million
- Net Margin
- 1.96%
- Return on Equity
- 2.18%
- Debt-to-Equity
- 0.54
- P/E Ratio
- 65.71
- Price / Book
- 1.41
- Price / Sales
- 1.27
Over the trailing twelve months, Pacira BioSciences, Inc. Common Stock generated revenue of $746.16 million and net income of $14.64 million, a net margin of 1.96%.
At the last closing price of $23.00, PCRX trades at 65.71 times trailing earnings and 1.27 times sales, with a market capitalization of $944.73 million.
Key Stats
- Last Close
- $23.00
- Market Cap
- $944.73 million
- 52-Week Range
- $18.80 – $27.66
- Average Volume
- 643K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.